NCT00003593 arm group 114111374b7e03433eab7a51e9a601aa [clinicaltrials_resource:NCT00003593/arm-group/114111374b7e03433eab7a51e9a601aa]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00003593 arm group 114111374b7e03433eab7a51e9a601aa [clinicaltrials_resource:NCT00003593/arm-group/114111374b7e03433eab7a51e9a601aa]
Bio2RDF identifier
NCT00003593/arm-group/114111374b7e03433eab7a51e9a601aa
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 4111374b7e03433eab7a51e9a601aa
description [clinicaltrials_vocabulary:description]
Patients are observed if their ...... ype of leukemia that develops.
identifier
clinicaltrials_resource:NCT00003593/arm-group/114111374b7e03433eab7a51e9a601aa
title
NCT00003593 arm group 114111374b7e03433eab7a51e9a601aa
@en
type
label
NCT00003593 arm group 11411137 ...... 111374b7e03433eab7a51e9a601aa]
@en